Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Metronidazole and Kefazolin for Postpartum Infection Prevention
NCT04792710Phase 4Unknown
- Sponsor
- University of Pretoria
- Start
- Mar 2021
- Primary completion
- Mar 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of metronidazole in Infection (2 arms), sponsored by University of Pretoria. Primary endpoint: Surgical Site Infection at 7 days. Status: unknown.
02
Drugs
metronidazole
03
Conditions
Infection
Beyond the preview
Go deeper on NCT04792710.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04792710.